Adagene Inc.
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
ADAG | US
Overview
Corporate Details
- ISIN(s):
- US0053291078
- LEI:
- Country:
- United States of America
- Address:
- 4F, BUILDING C14, NO. 218, XINGHU STREET, 0 JIANGSU
- Website:
- https://www.adagene.com/
Description
Adagene Inc. is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based immunotherapies. The company's core technology is built upon its understanding of protein folding and molecular motion to create a dynamic, multi-purpose antibody discovery engine. This platform utilizes precision engineering to identify and select antibody candidates with novel mechanisms of action, primarily for oncology applications. Adagene is advancing a proprietary pipeline of therapeutic assets and also leverages its technology through strategic collaborations with other biopharmaceutical companies to address challenging targets in cancer treatment.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Adagene Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Adagene Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Adagene Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
